Boston Scientific (BSX) financials
Boston Scientific revenue and earnings by year
Boston Scientific's revenue was $20.1 billion in the fiscal year to December 31, 2025, up 19.9% from the year before. Net income was $2.90 billion, 14.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.1 | 16.7 | 14.2 | 12.7 | 11.9 | 9.9 | 10.7 | 9.8 | 9.0 | 8.4 |
| Revenue growth | 19.9% | 17.6% | 12.3% | 6.7% | 19.9% | -7.7% | 9.3% | 8.6% | 7.9% | — |
| Gross profit | 13.9 | 11.5 | 9.9 | 8.7 | 8.2 | 6.4 | 7.6 | 7.0 | 6.5 | 6.0 |
| Gross margin | 69.0% | 68.6% | 69.5% | 68.8% | 68.8% | 65.0% | 71.0% | 71.4% | 71.3% | 71.1% |
| Operating income | 3.6 | 2.6 | 2.3 | 1.6 | 1.2 | -0.1 | 1.5 | 1.5 | 1.3 | 0.4 |
| Operating margin | 18.0% | 15.6% | 16.5% | 13.0% | 10.1% | -0.8% | 14.1% | 15.3% | 14.2% | 5.3% |
| Net income | 2.9 | 1.9 | 1.6 | 0.7 | 1.0 | -0.1 | 4.7 | 1.7 | 0.1 | 0.3 |
| Net margin | 14.4% | 11.1% | 11.2% | 5.5% | 8.8% | -0.8% | 43.8% | 17.0% | 1.1% | 4.1% |
| Diluted EPS | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | -$0.08 | $3.33 | $1.19 | $0.08 | $0.25 |
| Free cash flow | 3.7 | 2.6 | 1.8 | 1.0 | 1.4 | 1.2 | 1.4 | 0.0 | 1.1 | 0.8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BSX in Markets.
How Boston Scientific makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Cardiovascular | $3.62B | 66.6% |
| Medsurg | $1.82B | 33.4% |
See also: BSX valuation and P/E history · BSX returns
No forecast, no recommendation. This page describes Boston Scientific from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.